Overview
Pharmdiver develops tools for pharmaceutical and clinical data analysis to help healthcare professionals prevent inappropriate medication and supplement use. Its products include a checker for interactions between medicines, supplements and food, as well as tools for analysing adverse drug effects. The company serves healthcare professionals and manufacturers of medicines and supplements.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
2nd National Scientific Conference "Faces of Psychiatry in Clinical Pharmacy and Pharmaceutical Care"
Premiere of Smart Pharma Optimizer v2 solution
Webinar "Premiere of Smart Pharma Optimizer V2"
Pharmdiver article in Hospital Pharmacoeconomics
5 reasons why the oral dosage form decomposition module supports therapeutic teams' work
Is there room for a "grey zone" in pharmacotherapy safety?
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-08-04.
97 1090 1870 0000 0001 4747 8332- 74 1090 1694 0000 0001 5454 8542
- 81 1090 1694 0000 0001 5454 8610
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 21, 2022 | Aid for SME access to finance — aid for start-ups | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Feb 4, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | PREZYDENT MIASTA BIAŁEGOSTOKU |
Public procurement
1 tender recorded as contractor, with a total value of $54,822.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Apr 16, 2026 | Zakup, dostawa i wdrożenie oprogramowania AI wspierającego proces doboru leków przez lekarzy i farmaceutów w Uniwersyteckim Szpitalu Klinicznym w Opolu. | $54,822$54,822 | Uniwersytecki Szpital Kliniczny w Opolu |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by its sole member of the management board acting independently. In the case of a multi-member management board, making declarations of will and signing documents on behalf of the company requires joint action by two members of the management board, or by one member of the management board jointly with a commercial proxy, always including the member of the management board responsible for finance, if such a member of the management board has been appointed.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 262 | $3,538.63 | 46.6192% | |
Aleksandra Maria Burzyńska (45) | 84 | $1,134.52 | 14.9466% |
Marta Jasiewicz Badowska (42) | 83 | $1,121.02 | 14.7687% |
Jacek Andrzej Wiśniewski (59) | 80 | $1,080.50 | 14.2349% |
Others | 53 | $715.83 | 9.4306% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Chory.Plsp. z o.o. | $241,401.58 | chory.pl | ||
| IT Medico-Serwsp. z o.o. | $172,032.86 | it-medicoserw.pl | ||
| Fitlabssp. z o.o. | $155,223.18 | fitlabs.pl | ||
| Wiodsp. z o.o. | $65,432.75 | wiod.pl | ||
| Badania.Prosp. z o.o. | $51,818.28 | badania.pro | ||
| E-Tabletkasp. z o.o. | $41,991.06 | e-tabletka.pl | ||
| WellysaS.A. | $3,630.30 | wellysa.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-16 | Share capital change (21,050.00 PLN → 28,100.00 PLN) | |
| 2026-06-23 | Share capital change (12,650.00 PLN → 21,050.00 PLN) | |
| 2025-06-23 | Share capital change (10,100.00 PLN → 12,650.00 PLN) | |
| 2025-06-23 | Name change (Mak → Pharmdiver) | |
| 2024-08-27 | PKD change (Added: 72.19.Z, 85.59.B) |
FAQ
Last updated: 2026-10-03